Showing 1–25 of 200 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Margherita Bracchi, Clare van Halsema, Frank A. Post, Funmi Awosusi, Alison Barbour, et al.
…helped transform the management of TB in people living with HIV. The overall purpose of these guidelines is to help physicians manage adults with tuberculosis (TB)/human immunodeficiency virus (HIV) co-infection. Recommendations for the treatment of TB in HIV-positive adults are …
Dona Arlinda, Retna Mustika Indah, Aris Yulianto, Agus Dwi Harso, Armaji Kamaludi Syarief, et al.
…for tuberculosis (TB), multidrug-resistant (MDR) TB, and TB-HIV. We aimed to determine factors associated with poor TB treatment outcomes. A hospital-based TB Registry at seven referral hospitals in Java and Bali included data from patients aged ≥15 years who were diagnosed with …
Annelies Van Rie, Sujit Suchindran, Emily Brouwer
…of human suffering and death. Human immunodeficiency virus (HIV), multi-drug resistant TB (MDR-TB), and extensive drug resistant tuberculosis (XDR-TB) have emerged as threats to TB control. The association between MDR-TB and HIV infection has not yet been fully investigated. We c…
Anna Panova, Vadim Testov, Grigory Kaminskiy, Anastasia Samoilova, E. I. Veselova, et al.
…e 2010. Nevertheless the burden of MDR-TB and co-infection (HIV-TB) remains. <b>Aims:</b> To study drug resistance among new TB cases in HIV-positive patients (Pts) in comparison with HIV-negative pts. <b>Methods:</b> Multicentral study was performed in 6 Russian regions with hig…
S. V. Sklyuev, Д. В. Краснов, Yana Petrova, Е. П. Мышкова
…tal, 100 patients with MDR/XDR destructive TB combined with HIV infection participated in the study, of which 60 were randomized to EBV implantation (EBV group), and 40 patients to receive standard medical care (control group). <b>Results:</b> on day 2 of the study in 24(40.0%) p…
Anna Jazza, Eskedar Getie Mekonnen, Helen Cox, Annelies Van Rie
…R-TB and MDR-TB and assess potential effect modification by HIV status during treatment. Methods We conducted an individual patient data meta-analysis involving 16,651 individuals with confirmed drug-resistant tuberculosis, all of whom had drug susceptibility test results for at …
Prof Tubonye Harry, Dimie Ogoina, Dr Peter Nwakile, P. Ikuabe, Mr Jonathan Nanakede, et al.
shorter regimens, and 7 (13,2%) -with longer regimens (p < 0.05).Treatment outcomes were not evaluated in 6 patients (10,3%) who had started on shorter regimens and in 9 (17.0%)-on longer regimens (p > 0.05).One patient (1,7%) in the short regimen group died of TB and 2 (3.8%) in…
Alexandra Chizhova, Svetlana Safonova, Yulia Mikhajlova, М. А. Краснова, Anastasia Khakhalina, et al.
…(19.8% - 36.4%), and XDR-TB — 5.8% (2.4% - 11.7%). Among TB-HIV patients, there is a large share of DR strains for ethambutol (EMB) 35.0% (p = 0.0160), levofloxacin 20.0% (p = 0.005), and also for ofloxacin (OFL) 25.0% (p = 0.0019). The share of MDR-TB was significantly higher in…
Keertan Dheda, MD PhD
…suspected TB presenting to primary level TB clinics in high HIV prevalent settings. Tuberculosis (TB) is one of the world's most important infectious causes of mortality and continues to kill 1.8 million people annually. Despite intensified standard measure of TB control, TB cas…
Dipali Maganbhai Gavali, Binita Aring, Summiya Mullan, Akhlak Ahemad
…nd XDR-TB outbreaks have almost invariably been linked with HIV infection, resulting in exceptionally high patient mortality and highlighting the urgent need for rapid diagnosis and intervention in vulnerable populations, DM is a well-known risk factor for TB, and The epidemics o…
Zubeida Salaam-Dreyer, Elizabeth M. Streicher, Frederick A. Sirgel, Fabrizio Menardo, Sònia Borrell, et al.
…multidrug-resistant TB (MDR-TB) within a high TB, RR-TB and HIV burden setting. Patient-level clinical data and stored RR-TB isolates from 2008-2017 with available whole genome sequencing (WGS) data were used to describe risk factors associated with RMR-TB and to compare rifampic…
Silviа Borisova, Н. Б. Бородина
… treatment regimens for patients with such comorbidities as HIV infection and multiple drug resistant and extensively drug resistant tuberculosis. Subjects and Methods. Effectiveness and safety of chemotherapy regimens containing bedaquiline in the treatment of patients in 2017-2…
Erick Manuel Delgado Moya, Alain Piétrus, Sergio Oliva
…l takes into account the relationship between Tuberculosis, HIV/AIDS, and diabetes and differentiates resistance cases into MDR-TB (multidrug-resistant tuberculosis) and XDR-TB (extensively drug-resistant tuberculosis). We present the basic results associated with the model and s…
О. М. Raznatovska, А. В. Федорец, O. O. Furyk, H. I. Makurina, T. O. Hrekova, et al.
…atures of extensively drug-resistant tuberculosis (XDR-TB), HIV and tertiary syphilis co-infection course based on an example from own clinical experience.Materials and methods. A case report of XDR-TB with HIV and tertiary syphilis co-infection course was described based on our …
Argita D. Salindri, Maia Kipiani, Nino Lomtadze, Nestani Tukvadze, Zaza Avaliani, et al.
… tuberculosis (TB) (including human immunodeficiency virus [HIV], diabetes, and hepatitis C virus [HCV]) with post-TB mortality. We conducted a retrospective cohort study among persons who initiated treatment for rifampicin-resistant and multi/extensively drug-resistant (RR and M…
Leningrad Oblast Regional Anti-Tuberculosis Dispensary, Slantsy, Slantsevsky District, Leningrad Oblast, Russia, N.A. Barmina, Yu.V. Korneev, Leningrad Oblast Regional Anti-Tuberculosis Dispensary, Slantsy, Slantsevsky District, Leningrad Oblast, Russia
…/extensively drug-resistant (XDR) pathogens and people with HIV and TB co-infection. As a result, cases of TB disease in children with many risk factors for unfavorable outcome of therapy are recorded, leading to subsequent relapse. the aim of the work was to analyze possible cau…
Gourav Rakshit, Venkatesan Jayaprakash
… due to poor ROI, and the existence of co-infections; i.e., HIV, TB, COVID, and HIV-TB-COVID. Following our prior studies described by Stirret et al. in 2008, Ferreras et al. in 2011, and Shyam et al. in 2021, herein we focus on exploring pyrazoline-based mycobactin analogs (non-…
Larisa Rusakova, С. А. Стерликов, Vladimir Galkin
…e TB (4320) by registration group, age, gender, presence of HIV, proportion of rural population, frequency of bacterial excretion by smear microscopy. <b>Results:</b> In the XDR-TB group, patients prevailed after treatment failure (67.5% compared to 48.9% in the MDR-TB group and …
Nagender Prasad Chenimilla, Pravinya Pittala, Ramulu Madire
…e to the burden of TB. India is grouped under high TB, high HIV associated TB and MDR TB burden countries and 1.24 lakh fell ill with drug resistant TB out of which 56000 were started on second line treatment in 2020. Annually India accounts for 27% of missing TB cases. Diagnosis…
Eric R Houpt, MD
…iseases (NIH/NIAID) for US-Russia collaborative research in HIV/tuberculosis (TB). Given the exploratory focus of the protocol and the short time frame of funding (2 years) we will study TB in Irkutsk, in Eastern Siberia. Irkutsk is one of the hardest-hit areas in all of the Russ…
Ato Kwamena Tetteh, Edward Agyarko, Joseph Otchere, Langbong Bimi, Irène Ayi
A 25 year old HIV- seronegative client was diagnosed with pulmonary tuberculosis and placed on Category I (CAT I) treatment. After two months, acid fast bacilli (AFB) persisted in sputum. Rifampicin (Rif) resistance was detected with the GeneXpert MTB-Rif Assay® (Xpert; Cepheid, …
Amish Talwar, Clarisse A. Tsang, Sandy F. Price, Robert Pratt, William L. Walker, et al.
…ion on TB risk factors (e.g., human immunodeficiency virus [HIV] infection status, history of homelessness, and residence in a congregate setting). According to U.S. Census Bureau definitions, a “U.S.-born” person is classified as one born in the United States or a U.S. territory…
Ivana Beatrice Paulus, Feliani Sanjaya, Dewi Sukmawati
…uction: Tuberculosis (TB) and human immunodeficiency virus (HIV) are corelated infectious diseases and their worldwide spread became a global health problem. Moreover, HIV patients with TB are able to develop multi-drug resistance tuberculosis (MDR-TB) and extensive drug-resistan…
James CM Brust, MD, Gary Maartens, MBChB
…is a major global epidemic and poses a particular threat to HIV-infected individuals. With limited effective drugs available for treatment, multidrug-, and extensively drug-resistant TB carry a high mortality rate and threaten global TB and HIV control efforts. New and repurpose…
Patrick Howlett, Robert J. Wilkinson, Ben J. Marais
…linical features, Diagnosis, Tuberculosis treatment, TB and HIV, TB in Children, Treatment regimens, Multi-drug resistant and extensively drug resistant TB , Lessons learned in TB treatment and control